I interpret the silence to mean that no one else thought yesterday's PR was sleazy.
No, I'm with you. I think BPAX is trying to get across the point that NVS' success could pave the way for BPAX to secure additional non-exclusive licenses for the technology aside from the existing one with an undisclosed company. However, the PR does come across as a mindless pump.
Between this PR and the decision to spend precious resources on the GVAX program, coupled with the fact that so much of the value of the company is riding on a Phase 3 binary event for LibiGel, I'm less inclined to think of BPAX as worthy of investment and have pretty much dropped the stock from my watch list.
Market Data 
Markets 
AI
